Recent Advances in Immunotherapy for Mesothelioma
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 15 February 2026 | Viewed by 3
Special Issue Editor
Interests: mesothelioma; immunotherapy; tumor microenvironment; biomarkers; tumor heterogeneity
Special Issue Information
Dear Colleagues,
Malignant pleural mesothelioma (MPM) is an aggressive cancer primarily caused by asbestos exposure, with limited treatment options and a poor prognosis. Traditional therapies, like chemotherapy and surgery, offer modest survival benefits, prompting growing interest in immunotherapy as a promising alternative. Immune checkpoint inhibitors (ICIs), particularly anti-PD-1/PD-L1 and CTLA-4 antibodies, have demonstrated improved outcomes in selected patients and are now part of the standard of care for unresectable MPM. However, the response rate remains variable, and predictive biomarkers are not yet well defined. Tumor heterogeneity, an immunosuppressive tumor microenvironment, and low mutational burden present major challenges. Recent research focuses on combining ICIs with other modalities, such as chemotherapy, anti-angiogenic agents, or novel targets like mesothelin and tumor-associated macrophages. The goal is to enhance immune activation, overcome resistance mechanisms, and identify robust biomarkers with which to guide personalized therapy. The continued exploration of MPM immunobiology is critical to improving outcomes and expanding durable treatment responses.
Topics
- Immune checkpoint inhibitors (ICIs).
- Tumor immune microenvironment (TIME).
- EMT (epithelial–mesenchymal transition) and immunosuppression.
- BAP1, CDKN2A, and other genetic drivers.
- Multi-omics and systems biology approaches.
- Neoantigen prediction and cancer vaccines.
- Adoptive cell therapies.
- Clinical trials of immunotherapies in mesothelioma.
- Peritoneal mesothelioma.
- Bioinformatics and meta-analysis studies.
Dr. Licun Wu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesothelioma
- immunotherapy
- tumor microenvironment
- biomarkers
- tumor heterogeneity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
